| Mylaina Lyn Sherwood, MD | |
|
3415 Millers Run Rd, Cecil, PA 15321-1403 | |
| (724) 873-7414 | |
| (724) 873-7421 |
| Full Name | Mylaina Lyn Sherwood |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 3415 Millers Run Rd, Cecil, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427243245 | NPI | - | NPPES |
| P00754785 | Other | RAILROAD MEDICARE | |
| 1985059 | Other | PA | HIGHMARK |
| 730501 | Other | UPMC | |
| 1020140260004 | Medicaid | PA | |
| 276599 | Other | PA | UNISON |
| P010202 | Other | GATEWAY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | ML002805 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Washington Hospital, The | Washington, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington Hospital | 0446159313 | 21 |
| Whs Inpatient Services, Pllc | 2668601394 | 25 |
News Archive
A multi-national team of researchers compared COVID-19-related data from different countries in order to better understand the various factors leading to the different results across the world. The multi-disciplinary team included data scientists, software developers, and an infectious diseases physician.
To kick off the holiday season, Emeritus Senior Living has launched a video series that provides valuable tips and information to help seniors – and those who love and care for them – lead safer and healthier lives.
Although calcium supplements might prevent development of polyps that sometimes lead to colon cancer, there is not enough evidence that the mineral can prevent colorectal cancer itself, according to a new study.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
Sanofi US announced today results of the pivotal SAVE-ONCO study which demonstrated that, in cancer patients initiating a chemotherapy regimen, investigational semuloparin significantly reduced the risk of the composite of symptomatic-deep vein thromboembolism (DVT), non-fatal pulmonary embolism (PE) or venous thromboembolism (VTE)-related death by 64%, meeting the study primary endpoint.
› Verified 5 days ago
| Entity Name | Washington Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1922077205 PECOS PAC ID: 0446159313 Enrollment ID: O20050420000827 |
News Archive
A multi-national team of researchers compared COVID-19-related data from different countries in order to better understand the various factors leading to the different results across the world. The multi-disciplinary team included data scientists, software developers, and an infectious diseases physician.
To kick off the holiday season, Emeritus Senior Living has launched a video series that provides valuable tips and information to help seniors – and those who love and care for them – lead safer and healthier lives.
Although calcium supplements might prevent development of polyps that sometimes lead to colon cancer, there is not enough evidence that the mineral can prevent colorectal cancer itself, according to a new study.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
Sanofi US announced today results of the pivotal SAVE-ONCO study which demonstrated that, in cancer patients initiating a chemotherapy regimen, investigational semuloparin significantly reduced the risk of the composite of symptomatic-deep vein thromboembolism (DVT), non-fatal pulmonary embolism (PE) or venous thromboembolism (VTE)-related death by 64%, meeting the study primary endpoint.
› Verified 5 days ago
| Entity Name | Whs Inpatient Services, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427485804 PECOS PAC ID: 2668601394 Enrollment ID: O20140129001062 |
News Archive
A multi-national team of researchers compared COVID-19-related data from different countries in order to better understand the various factors leading to the different results across the world. The multi-disciplinary team included data scientists, software developers, and an infectious diseases physician.
To kick off the holiday season, Emeritus Senior Living has launched a video series that provides valuable tips and information to help seniors – and those who love and care for them – lead safer and healthier lives.
Although calcium supplements might prevent development of polyps that sometimes lead to colon cancer, there is not enough evidence that the mineral can prevent colorectal cancer itself, according to a new study.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
Sanofi US announced today results of the pivotal SAVE-ONCO study which demonstrated that, in cancer patients initiating a chemotherapy regimen, investigational semuloparin significantly reduced the risk of the composite of symptomatic-deep vein thromboembolism (DVT), non-fatal pulmonary embolism (PE) or venous thromboembolism (VTE)-related death by 64%, meeting the study primary endpoint.
› Verified 5 days ago
| Entity Name | Waynesburg Inpatient Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013388628 PECOS PAC ID: 0840593224 Enrollment ID: O20160119000828 |
News Archive
A multi-national team of researchers compared COVID-19-related data from different countries in order to better understand the various factors leading to the different results across the world. The multi-disciplinary team included data scientists, software developers, and an infectious diseases physician.
To kick off the holiday season, Emeritus Senior Living has launched a video series that provides valuable tips and information to help seniors – and those who love and care for them – lead safer and healthier lives.
Although calcium supplements might prevent development of polyps that sometimes lead to colon cancer, there is not enough evidence that the mineral can prevent colorectal cancer itself, according to a new study.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
Sanofi US announced today results of the pivotal SAVE-ONCO study which demonstrated that, in cancer patients initiating a chemotherapy regimen, investigational semuloparin significantly reduced the risk of the composite of symptomatic-deep vein thromboembolism (DVT), non-fatal pulmonary embolism (PE) or venous thromboembolism (VTE)-related death by 64%, meeting the study primary endpoint.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mylaina Lyn Sherwood, MD 95 Leonard Ave, Bldg 2, Washington, PA 15301-3368 Ph: (724) 223-3100 | Mylaina Lyn Sherwood, MD 3415 Millers Run Rd, Cecil, PA 15321-1403 Ph: (724) 873-7414 |
News Archive
A multi-national team of researchers compared COVID-19-related data from different countries in order to better understand the various factors leading to the different results across the world. The multi-disciplinary team included data scientists, software developers, and an infectious diseases physician.
To kick off the holiday season, Emeritus Senior Living has launched a video series that provides valuable tips and information to help seniors – and those who love and care for them – lead safer and healthier lives.
Although calcium supplements might prevent development of polyps that sometimes lead to colon cancer, there is not enough evidence that the mineral can prevent colorectal cancer itself, according to a new study.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
Sanofi US announced today results of the pivotal SAVE-ONCO study which demonstrated that, in cancer patients initiating a chemotherapy regimen, investigational semuloparin significantly reduced the risk of the composite of symptomatic-deep vein thromboembolism (DVT), non-fatal pulmonary embolism (PE) or venous thromboembolism (VTE)-related death by 64%, meeting the study primary endpoint.
› Verified 5 days ago
Donald J Faith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3415 Millers Run Rd, Cecil, PA 15321 Phone: 724-873-7414 Fax: 724-872-7421 | |
Sarah Carolyn Duncan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3415 Millers Run Rd, Cecil, PA 15321 Phone: 724-873-7414 Fax: 724-873-7421 |